Evidence map›Paper›PMID 37149522›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Carbohydrate Depolymerization by Intricate Cellulosomal Systems.

Sarah Moraïs, Johanna Stern, Lior Artzi, Carlos M G A Fontes, Edward A Bayer, Itzhak Mizrahi

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sarah MoraïsFaculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Johanna SternDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Lior ArtziDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Carlos M G A FontesNZYTech Genes & Enzymes, Lisbon, Portugal.
Edward A BayerFaculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. ed.bayer@weizmann.ac.il.ORCID 0000-0001-7749-5150
Itzhak MizrahiFaculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ben-Gurion University of the Negev · ILWeizmann Institute of Science · ILNzytech (Portugal) · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellulosomes are multi-enzymatic nanomachines that have been fine-tuned through evolution to efficiently deconstruct plant biomass. Integration of cellulosomal components occurs via highly ordered protein-protein interactions between the various enzyme-borne dockerin modules and the multiple copies of the cohesin modules located on the scaffoldin subunit. Recently, designer cellulosome technology was established to provide insights into the architectural role of catalytic (enzymatic) and structural (scaffoldin) cellulosomal constituents for the efficient degradation of plant cell wall polysaccharides. Owing to advances in genomics and proteomics, highly structured cellulosome complexes have recently been unraveled, and the information gained has inspired the development of designer-cellulosome technology to new levels of complex organization. These higher-order designer cellulosomes have in turn fostered our capacity to enhance the catalytic potential of artificial cellulolytic complexes. In this chapter, methods to produce and employ such intricate cellulosomal complexes are reported.

Indexed as

CelluloseCellulosomesBacterial ProteinsCell Cycle ProteinsCell MembraneCell WallGenomicsBacterial ProteinsCell Cycle ProteinsCelluloseCellulaseCelluloseCellulosomeMulti-enzymatic complexXylanase

Identifiers

PMID37149522
OpenAlexW4375824633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.